AGENT FOR USE IN THE CASE OF FRUCTOSE INTOLERANCE

An agent is described that, with the help of glucose isomerase, converts fructose into glucose and thus, alone or in combination with 5-D-fructose dehydrogenase, reduces the bioavailability of fructose in the human or animal body. This agent can be used in particular in the therapy of fructose intol...

Full description

Saved in:
Bibliographic Details
Main Authors Wyrobnik, Daniel Henry, Wyrobnik, Isaac Harry
Format Patent
LanguageCroatian
English
Published 06.04.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:An agent is described that, with the help of glucose isomerase, converts fructose into glucose and thus, alone or in combination with 5-D-fructose dehydrogenase, reduces the bioavailability of fructose in the human or animal body. This agent can be used in particular in the therapy of fructose intolerance.
Bibliography:Application Number: HR2018P000219T